Published in Lancet on July 17, 1993
Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory. J Clin Pathol (2005) 1.22
Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center. BMC Med Inform Decis Mak (2015) 1.05
What Is Asked in Clinical Data Request Forms? A Multi-site Thematic Analysis of Forms Towards Better Data Access Support. AMIA Annu Symp Proc (2014) 0.86
Design of pathology request forms. Lancet (1993) 0.75
Design of pathology request forms. Lancet (1993) 0.75
Controlled study of malathion and d-phenothrin lotions for Pediculus humanus var capitis-infested schoolchildren. Lancet (1995) 4.16
Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci U S A (1988) 3.11
SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol (2000) 3.06
Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet (1998) 2.89
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis (1995) 2.89
Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology (1994) 2.45
Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med (1998) 2.31
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol (1995) 2.16
Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (1993) 2.05
Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol (2001) 2.04
Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol (1992) 2.01
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology (1990) 2.00
Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol (1995) 1.98
Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol (2002) 1.91
The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol (1987) 1.69
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology (2005) 1.65
Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas. Arch Dermatol (1995) 1.64
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol (1987) 1.62
Neurological complications of neurofibromatosis type 1 in adulthood. Brain (1999) 1.58
A 20-year experience of electron microscopy in the diagnosis of primary ciliary dyskinesia. Eur Respir J (2009) 1.58
Pachydermodactyly and atrophia maculosa varioliformis cutis. Dermatology (1995) 1.57
Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients. Arch Dermatol (1994) 1.57
The significance of a single periungual fibroma: report of seven cases. Arch Dermatol (1995) 1.56
Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med (1995) 1.53
Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol (2000) 1.52
Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol (2001) 1.50
Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients. Arch Dermatol (1996) 1.50
A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia. Proc Natl Acad Sci U S A (1989) 1.48
Diabetic control in 102 insulin-treated out-patients. Diabetologia (1980) 1.47
Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol (1987) 1.45
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology (1999) 1.45
Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol (1995) 1.43
Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion (1997) 1.42
Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis. Br J Dermatol (1994) 1.42
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood (1997) 1.40
[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. J Hum Hypertens (2010) 1.40
[Isotretinoin in danger! So are the dermatologists!]. Ann Dermatol Venereol (2005) 1.40
Infliximab-induced acne: report of two cases. Br J Dermatol (2007) 1.40
Impact of smoking on histological liver lesions in chronic hepatitis C. Gut (2003) 1.40
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol (2015) 1.39
Hypothermia related to air-fluidized bed. Intensive Care Med (1991) 1.39
[Medical activity in a emergency outpatient department dermatology]. Ann Dermatol Venereol (2003) 1.38
Comparative analysis of severe aphthosis and Behçet's disease: 104 cases. Dermatology (1999) 1.38
Prenatal diagnosis of sickle-cell anemia in the first trimester of pregnancy. N Engl J Med (1983) 1.35
Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis (1996) 1.34
Biochemical characterisation of a serum thymic factor. Nature (1977) 1.33
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat (2007) 1.29
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28
Severe cutaneous reactions to self-defense sprays. Arch Dermatol (1993) 1.28
Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol (1996) 1.27
Isolation and identification of a cDNA clone coding for rat uroporphyrinogen decarboxylase. Proc Natl Acad Sci U S A (1984) 1.27
Acute chest syndrome in adults with sickle cell disease. Chest (2000) 1.27
The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection. J Infect Dis (1998) 1.26
Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol (1994) 1.26
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol (1998) 1.25
Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol (2005) 1.23
Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A (1986) 1.23
Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection. J Infect Dis (1999) 1.23
Molecular cloning of a cDNA sequence complementary to porphobilinogen deaminase mRNA from rat. Proc Natl Acad Sci U S A (1984) 1.22
Acquired immunodeficiency syndrome in France. Lancet (1983) 1.21
Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease. Gastroenterology (1989) 1.20
Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. J Clin Invest (1989) 1.19
Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol (2005) 1.18
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat (1999) 1.16
Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br J Ophthalmol (2004) 1.16
Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet (2000) 1.16
Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med (1997) 1.15
Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. J Infect Dis (1996) 1.14
Platelet transfusion: a dose-response study. Blood (1998) 1.13
Beta-chain contact sites in the haemoglobin S polymer. Nature (1980) 1.13
Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis (1999) 1.13
The impact of the prevention programme of hepatitis C over more than a decade: the French experience. J Viral Hepat (2009) 1.11
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat (2013) 1.10
Effect of thyroid hormones on the switch from larval to adult hemoglobin synthesis in the salamander Pleurodeles waltlii. Cell Differ (1982) 1.10
Tinea capitis in adults: misdiagnosis or reappearance? Dermatology (1997) 1.10
Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol (1995) 1.09
Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther (2003) 1.09
Study of folate in psoriasis: blood levels, intestinal absorption and cutaneous loss. Br J Dermatol (1973) 1.08
Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol (1990) 1.08
Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol (1998) 1.07
Cloning and sequencing of mRNAs coding for two adult alpha globin chains of the salamander Pleurodeles waltlii. Gene (1986) 1.07
Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat (2004) 1.07
Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol (1999) 1.06
Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation (1999) 1.05
Drug-induced severe skin reactions. Incidence, management and prevention. Drug Saf (1995) 1.05
Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs. Br Med J (Clin Res Ed) (1985) 1.03
The peculiar spectrum of beta-thalassemia genes in Tunisia. Hum Genet (1988) 1.02
Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol (1989) 1.02
Diphosphoglycerate mutase and 2,3-diphosphoglycerate phosphatase activities of red cells: comparative electrophoretic study. Biochem Biophys Res Commun (1973) 1.01
Abnormal central complex is a marker of severity in the presence of partial ciliary defect. Pediatrics (2001) 1.01
Graft versus host reaction and lichen planus. Br J Dermatol (1975) 1.01